SkinBioTherapeutics (SBTX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 9.85p
   
  • Closing Price Chg:
      0.000p
  • 52 Week High: 9.85
  • 52 Week Low: 9.70
  • Currency: UK Pounds
  • Shares Issued: 259.04m
  • Volume: 0
  • Market Cap: £25.52m

Latest ShareCast News

Skinbiotherapeutics brings in new audit chair, launches forensic review

By Iain Gilbert

Date: Friday 20 Feb 2026

(Sharecast News) - Life science business SkinBioTherapeutics said on Friday that it has appointed Alyson Levett as a new non‑executive director and chair of the audit committee, with responsibility for overseeing the ongoing investigation into the conduct of its former chief executive and the validity of royalty income booked in its FY25 accounts.

SkinBioTherapeutics dives on warning of major FY25 revenue restatement

By Iain Gilbert

Date: Monday 16 Feb 2026

(Sharecast News) - Life sciences company SkinBioTherapeutics traded sharply lower early on Monday after revealing an internal investigation had raised serious concerns over the conduct of its former chief executive and the validity of royalty income booked in its FY25 accounts.

SkinBioTherapeutics CEO resigns

By Iain Gilbert

Date: Friday 13 Feb 2026

(Sharecast News) - Life science business SkinBioTherapeutics said on Friday that chief executive Stuart Ashman has resigned, having been suspended by the board pending an investigation into matters relating to his conduct.

Holding(s) in Company 02-Jan-2026 ShareCast
Result of AGM 29-Dec-2025 ShareCast
Holding(s) in Company 29-Dec-2025 ShareCast
SkinBioTherapeutics revenue rises fourfold, stil... 14-Aug-2025 ShareCast
SkinBioTherapeutics inks Superdrug deal, raises ... 16-Jun-2025 ShareCast
SkinBioTherapeutics shares jump on acquisition o... 11-Oct-2024 ShareCast
SkinBioTherapeutics reports positive results fro... 19-Sep-2024 ShareCast
SkinBioTherapeutics secures £1.56m from new inve... 02-Aug-2024 ShareCast
SkinBioTherapeutics reports better-than-expected... 29-Jul-2024 ShareCast
SkinBioTherapeutics reports positive interim acn... 27-Feb-2024 ShareCast
SkinBioTherapeutics finalises acquisition of Der... 26-Jan-2024 ShareCast
SkinBioTherapeutics launches new consumer study ... 25-Oct-2023 ShareCast
SkinBioTherapeutics gets France approval for pso... 15-Sep-2023 ShareCast
SkinBioTherapeutics selects probiotic blends for... 05-Sep-2023 ShareCast
SkinBioTherapeutics launching psoriasis suppleme... 21-Jun-2023 ShareCast
SkinBioTherapeutics pleased with progress on two... 10-May-2023 ShareCast
SkinBioTherapeutics reports progress with psoria... 17-Feb-2022 ShareCast
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

SBTX Market Data

Currency UK Pounds
Share Price 9.85p
Closing Price Change 0.000p
% Change 0.00 %
52 Week High 9.85
52 Week Low 9.70
Volume 0
Shares Issued 259.04m
Market Cap £25.52m

SBTX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
71.12% below the market average71.12% below the market average71.12% below the market average71.12% below the market average71.12% below the market average
75.61% below the sector average75.61% below the sector average75.61% below the sector average75.61% below the sector average75.61% below the sector average
Price Trend
36.07% below the market average36.07% below the market average36.07% below the market average36.07% below the market average36.07% below the market average
9.09% below the sector average9.09% below the sector average9.09% below the sector average9.09% below the sector average9.09% below the sector average
Income Not Available
Growth
49.92% above the market average49.92% above the market average49.92% above the market average49.92% above the market average49.92% above the market average
72.41% above the sector average72.41% above the sector average72.41% above the sector average72.41% above the sector average72.41% above the sector average

SBTX Dividends

No dividends found

Trades for --2026

Time Volume / Share Price
0 @ 0.000p

SBTX Key Personnel

CEO Stuart Ashman
CFO Emily Bertram

Top of Page